Gene description
Orthologous
GO biological process
pentacyclic triterpenoid biosynthetic process
GO cellular component
nucleus
GO molecular function
lupeol synthase activity, nucleic acid binding, beta-amyrin synthase activity, lupan-3beta,20-diol synthase activity
Protein domain
Pfam | PF13243, Squalene-hopene cyclase C-terminal domain |
Pfam | PF13249, Squalene-hopene cyclase N-terminal domain |
Metabolic pathway
Coexpression network
Differentially expressed condition
17 conditions
Series | Control | Treatment | Log2FC | Adj. P value |
---|---|---|---|---|
GSE12856 | Col, WT, control | Col, WT, Bg h | -1.55 | 4.33E-05 |
GSE12856 | Col, ataf1, control | Col, ataf1, Bg h | -1.57 | 3.08E-05 |
GSE26679 | Col, WT, GC 0 h | Col, WT, GC 18 h | 2.91 | 2.13E-10 |
GSE26679 | Col, WT, GC 0 h | Col, WT, GC 36 h | 2.85 | 2.59E-10 |
GSE26679 | Col, edr1, GC 0 h | Col, edr1, GC 18 h | 2.60 | 1.37E-09 |
GSE26679 | Col, edr1, GC 0 h | Col, edr1, GC 36 h | 3.23 | 1.57E-11 |
GSE37269 | Ei2, WT, control | Ei2, WT, TEV 21 d | -4.97 | 3.05E-08 |
GSE37269 | Ler0, WT, control | Ler0, WT, TEV 21 d | -2.40 | 4.31E-03 |
GSE37269 | St0, WT, control | St0, WT, TEV 21 d | -2.55 | 1.17E-03 |
GSE37921 | Col, WT, control | Col, WT, CMV | -1.80 | 3.51E-04 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 12 h | -1.50 | 4.52E-10 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 4 h | -1.75 | 5.80E-11 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 8 h | -1.95 | 8.57E-12 |
GSE45214 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 4 h | -2.10 | 1.29E-10 |
GSE5520 | Col, WT, control 10 h | Col, WT, Cor- 10 h | -2.33 | 5.88E-03 |
GSE5520 | Col, WT, control 10 h | Col, WT, Cor- hrpS- 10 h | -2.22 | 3.95E-02 |
GSE58954 | Col, WT, Psm AvrRpt2 0 h | Col, WT, Psm AvrRpt2 6 h | -2.75 | 1.71E-03 |
Copyright © 2017 Ziding Zhang's Lab - China Agricultural University. All Rights Reserved.